THE MANY FACES OF PSORIATIC ARTHRITIS: THE DIFFICULTIES OF TIMELY DIAGNOSIS IN RHEUMATOLOGY AND DERMATOLOGY

DOI: https://doi.org/10.29296/25877305-2024-06-02
Issue: 
6
Year: 
2024

Associate Professor E. Kapustina, Candidate of Medical Sciences; D. Filipenko;
A. Vasilyeva; Professor P. Shesternya, MD; A. Chernova; T. Potupchik, Candidate of Medical Sciences; A. Klennikova; D. Tolstikhina
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry
of Health of Russia

The review is devoted to the analysis of current data on the prevalence, clinical picture, differential, instrumental diagnosis of psoriatic arthritis (PsA). The incidence rate PsA is 6–42% of all patients with psoriasis. In recent years, there has been a significant increase in the incidence of PsA. The main clinical manifestations of PsA are: peripheral arthritis, enteritis, dactyl, spondylitis. Timely diagnosis of PsA is an urgent and unresolved healthcare task. Interdisciplinary interaction of a dermatologist, a general practitioner, a rheumatologist and an in-depth examination based on the results of mPEST screening is necessary in order to detect this pathology early.
Keywords: 
psoriatic arthritis
psoriasis
spondyloarthritis
diagnosis
screening.

References: 
  1. Gladman D.D., Antoni C., Mease P. et al. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005; 64 (2): 14–7. DOI: 10.1136/ard.2004.032482
  2. Клинические рекомендации. Псориаз артропатический. Псориатический артрит. 2021 [Clinical recommendations. Arthropathic psoriasis. Psoriatic arthritis. 2021 (in Russ.)]. URL: https://cr.minzdrav.gov.ru/recomend/562_2
  3. Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость периферических и аксиальных проявлений псориатического артрита у больных псориазом в дерматологической практике. Современная ревматология. 2019; 13 (4): 48–54 [Chamurlieva M.N., Loginova E.Yu., Korotaeva T.V. Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice. Modern Rheumatology Journal. 2019; 13 (4): 48–54 (in Russ.)]. DOI: 10/14412/1996-7012-2019-4-48-54
  4. Poddubnyy D., Jadon D.R., Van den Bosch F. et al. Axial involvement in psoriatic arthritis: An update for rheumatologists. Semin Arthritis Rheum. 2021; 51 (4): 880–7. DOI: 10.1016/j.semarthrit.2021.06.006
  5. Armstron A., Bohannan B., Mburu S. et al. Impact of Psoriatic Disease on Quality of Life: Interim Results of a Global Survey. Dermatol Ther (Heidelb). 2022; 12: 1055–64. DOI: 10.1007/s13555-022-00695-0
  6. Olivieri I., Padula A., D’Angelo S. et al. Psoriatic arthritis sine psoriasis. J Rheumatol. 2009; Suppl 83: 28–9. DOI: 10.3899/jrheum.090218
  7. Eder L., Haddad A., Rosen C.F. et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheum. 2016; 68: 915–23. DOI: 10.1002/art.39494
  8. Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость псориатического артрита у больных псориазом в дерматологической и ревматологической клинике. Современная ревматология. 2016; 10 (4): 47–50 [Chamurlieva M.N., Loginova E.Yu., Korotaeva T.V. Detection rates of psoriatic arthritis in patients with psoriasis in a dermatology and rheumatology clinic. Modern Rheumatology Journal. 2016; 10 (4): 47–50 (in Russ.)]. DOI: 10.14412/1996-7012-2016-4-47-50
  9. Ritchlin C.T., Colbert R.A., Gladman D.D. Psoriatic Arthritis. N Engl J Med. 2017; 376: 957–70. DOI: 10.1056/NEJMra1505557
  10. Mease P.J. Psoriatic arthritis: Update on pathophysiology, assessement and management. Ann Rheum Dis. 2011; 70 (Suppl 1): 77–84. DOI: 10.1136/ard.2010.140582
  11. Коротаева Т.В. Псориатический артрит: патогенетическое обоснование современных терапевтических подходов. Доктор.Ру. 2021; 20 (7): 19–25 [Korotaeva T.V. Psoriatic Arthritis: Pathogenetic Justification of Current Therapeutic Approaches. Doctor.Ru. 2021; 20 (7): 19–25 (in Russ.)]. DOI: 10.31550/1727-2378-2021-20-7-19-25
  12. Коротаева Т.В., Корсакова Ю.Л. Псориатический артрит: классификация, клиническая картина, диагностика, лечение. Научно-практическая ревматология. 2018; 56 (1): 60–9 [Korotaeva T.V., Korsakova Yu.L. Psoriatic arthritis: classification, clinical presentation, diagnosis, treatment. Rheumatology Science and Practice. 2018; 56 (1): 60–9 (in Russ.)]. DOI: 10.14412/1995-4484-2018-60-69
  13. Khan M., Schentag C., Gladman D.D. Clinical and radiological changes during psoriatic arthritis disease progression. J Rheumatol. 2003; 30: 1022–6.
  14. Gladman D.D., Ziouzina O., Thavaneswaran A. et al. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. J Rheumatol. 2013; 40: 1357–9. DOI:10.3899/jrheum.130163
  15. Koppikara S., Edera L. The management of enthesitis in clinical practice. Curr Opin Rheumatol. 2020; 32 (4): 380–6. DOI: 10.1097/BOR.0000000000000715
  16. Егудина Е.Д., Триполка С.А. Энтезит – ключ к диагнозу спондилоартрита, акцент на псориатический артрит. Современная ревматология. 2021; 15 (1): 79–86 [Yehudina Ye.D., Trypolka S.А. Enthesitis is a clue to the diagnosis of spondyloarthritis, focus on psoriatic arthritis. Modern Rheumatology Journal. 2021; 15 (1): 79–86 (in Russ.)]. DOI: 10.14412/1996-7012-2020-3-79-86
  17. Macchioni P., Salvarani C., Possemato N. et al. Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: the ULISSE Study. J Rheumatol. 2019; 46 (8): 904–11. DOI: 10.3899/jrheum. 171411
  18. Palominos P.E., de Campos A.P.B., Ribeiro S.L.E. et al. Correlation of enthesitis indices with disease activity and function in axial and peripheral spondyloarthritis: a crosssectional study comparing MASES, SPARCC and LEI. Adv Rheumatol. 2019; 59 (1): 23. DOI: 10.1186/s42358-019-0066-8
  19. Губарь Е.Е., Логинова Е.Ю., Корсакова Ю.Л. и др. Возможности скрининга высокого риска поражения осевого скелета при псориатическом артрите. Современная ревматология. 2020; 14 (3): 34–8 [Gubar E.E., Loginova E.Yu., Korsakova Yu.L. et al. Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis. Modern Rheumatology Journal. 2020; 14 (3): 34–8 (in Russ.)]. DOI: 10/14412/1996-7012-2020-3-34-38
  20. Coates L.C., Aslam T., Al Balushi F. et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol. 2013; 168: 802–7. DOI: 10.1111/bjd.12190
  21. Iragorri N., Hazlewood G., Manns B. et al. Psoriatic arthritis screening: a systematic review and meta-analysis. Rheumatology (Oxford). 2019; 58 (4): 692–707. DOI: 10.1093/rheumatology/key314
  22. Chandran V. Barrett J., Schentag N.C. et al. Axial Psoriatic Arthritis: update on a longterm prospective study. J Rheumatol. 2009; 36: 2744–50. DOI: 10.3899/jrheum.090412
  23. Коротаева Т.В., Корсакова Ю.Л., Логинова Е.Ю. и др. Псориатический артрит. Клинические рекомендации по диагностике и лечению. Современная ревматология. 2018; 12 (2): 22–35 [Korotaeva T.V., Korsakova Yu.L., Loginova E.Yu. et al. Psoriatic arthritis. Clinical guidelines for diagnosis and treatment. Modern Rheumatology Journal. 2018; 12 (2): 22–35 (in Russ.)]. DOI: 10/14412/1996-7012-2018-2-22-35
  24. Qureshi A.A., Husni M.E., Mody E. Psoriatic arthritis and psoriasis: need for a multidisciplinary approach. Semin Cutan Med Surg. 2005; 24: 46–51. DOI: 10.1016/j.sder.2005.01.006